Drugs / TongBi Capsule
last change Oct 2019 re-read 3 minutes ago

TongBi Capsule

Developed for
osteoarthritis, knee
Investigated by
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03418155 Feb 2018 → Apr 2019 osteoarthritis, knee Guang'anmen Hospital of China Academy of Chinese Medical Sciences Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TongBi Capsule ClinicalTrials.gov intervention name — accepted as the source's own label NCT03418155 ↗
Route Oral “TongBi Capsule:0.31g,3times a day, oral, for 4 weeks.” NCT03418155 ↗